SpringerLink
Log in

Enteral Nutrition Therapy: Which Formula Do You Use?

  • Nutrition and Obesity (O Pickett-Blakely, Section Editor)
  • Published:
Current Treatment Options in Gastroenterology Aims and scope Submit manuscript

Abstract

Purpose of Review

Optimal nutritional status is crucial for the well-being and quality of life of patients who suffer with gastrointestinal disorders due to the significant impairments that can occur through oral tolerance and acceptance, digestive absorption and motility, and weight management. For patients who demonstrate an inability to sustain their nutrition and weight orally, enteral nutrition is an appropriate intervention to help meet nutrient needs. Despite established consensus on indications for the initiation of enteral nutrition, there has been a lack of clear guidelines on proper formulary in respect to gastrointestinal dysfunction. This review focused on the current research comparing the use of standard and peptide-based formulas in respect to gastrointestinal disorders such as inflammatory bowel disease, short bowel syndrome and intestinal failure, pancreatic insufficiency, and gastroparesis.

Recent Findings

In summarization of the findings, it was concluded that as a preliminary intervention, a standard, polymeric formulary is an appropriate, cost-effective approach; however, if poor tolerance or response is demonstrated, transitioning to a hydrolyzed formulary is warranted.

Summary

As concluded by many of the authors included within this review, a principal takeaway is the importance of demonstrating that the additional expenditure of a specialty formula will realize an improved outcome for the patient and an overall efficient use of resources. One of the limitations found throughout this review is the lack of guidelines for enteral formula recommendations or changes in the clinical outpatient setting, being that most research has focused on an acute care population; however, these settings may still be of best guidance for the treatment of patients experiencing flares, persistent gastrointestinal distress, or poor medical response.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Damas OM, Garces L, Abreu MT. Diet as adjunctive treatment for inflammatory bowel disease: review and update of the latest literature. 2019;17:313–25.

    Google Scholar 

  2. Logan M., Gikakas K., et al. Analysis of 61 exclusive enteral nutrition formulas used in the management of active Crohn’s disease—new insights into dietary disease triggers. 2020 51:935–947

  3. Seres DS, Ippolito PR. Pilot study evaluating the efficacy, tolerance and safety of a peptide-based enteral formula versus a high protein enteral formula in multiple ICU settings (medical, surgical, cardiothoracic). 2017 36: 706–709

  4. Limketkai BN, Shah ND, Sheikh GN, et al. classifying enteral nutrition: tailored for clinical practice. 2019 21:47 This review suggests that in most cases, the use of a standard polymeric formula would suffice. However, for patients with gastrointestinal intolerance or malabsorptive issues, a peptide-based formula could be considered. While exclusive enteral nutrition is helpful for Crohn’s Disease, there is so far no evidence that specialized formulas provide any benefit beyond the standard polymeric formula.

  5. Narula N, Dhillon A, Zhang D, Sherlock ME, Tondeur M, Zachos M. Enteral nutritional therapy for induction of remission in Crohn's disease. (2018) 4:4

  6. Curry AS, Chadda S, Danel A, Nguyen DL. Early introduction of a semi-elemental formula may be cost saving compared to a polymeric formula among critically ill patients requiring enteral nutrition: a cohort cost-consequence model. 2018 10:293–300 The American Society of Parenteral and Enteral Nutrition and Society of Critical Care Medicine guidelines note that “no clear benefit to patient outcome has been shown in the literature for the routine use of specialty formulas in a general ICU setting” (expert consensus) and that “small peptide formulations should be used in the patient with persistent diarrhea, with suspected malabsorption or lack of response to fiber” (expert consensus).

  7. Triantafillidis JK, Vagianos C, Papalois AE. (2015). The role of enteral nutrition in patients with inflammatory bowel disease: current aspects. 2015: 197167

  8. Alexander DD, Bylsma LC, Elkayam L, Nguyen DL. (2016). Nutritional and health benefits of semi-elemental diets: a comprehensive summary of the literature. 7:306–319 A study comparing a peptide-based diet with an amino acid-based elemental diet found similar clinical remission rates in the amino acid group compared with the peptide group. The authors concluded that peptide-based diets are equally efficacious as amino acid-based diets in terms of high rates of clinical remission and is better tolerated orally.

  9. Hartman C, Eliakim R, Shamir R. Nutritional status and nutritional therapy in inflammatory bowel diseases. 2009 15:2570-2578

  10. Smith PA. Nutritional therapy for active Crohn’s disease. 2008;14:4420–3.

    Google Scholar 

  11. Kanthasamy KA, Venkata SA, Vikesh KS. Nutritional management of acute pancreatitis. 2021 50:141–150 Two meta-analyses within the review compared semi-elemental with polymeric formulations and found no difference in terms of feeding intolerance, mortality, or length of stay between the two formulations. The authors within this review concluded that there is no apparent clinical advantage to the use of oligomeric formulations and more inexpensive polymeric formulations should be readily used.

  12. Makola D, Krenitsky J, Rees Parrish C. Enteral feeding in acute and chronic pancreatitis. 2007 17:747-764

  13. Wong T, Gupte G. Complications of short bowel syndrome. 2019;29:389–93.

    Google Scholar 

  14. Vanderhoof JA, Young RJ. Enteral nutrition in short bowel syndrome. 2001;10:65–71.

    CAS  Google Scholar 

  15. Vanderhoof JA, Young RJ. Enteral and parenteral nutrition in the care of patients with short-bowel syndrome. 2003;17:997–1015.

    Google Scholar 

  16. Matarese LE, Harvin G. Nutritional care for patients with intestinal failure. 2021 50:201–216 This review summarizes that, in general for patients with short bowel syndrome, the more complex the nutrient formulation (ie, complex carbohydrates, fats, and protein), the more likely the patient will tolerate the formula and the more likely there is to be stimulation of intestinal adaptation. For those individuals who are intolerant to complex formulas, defined formula diets that have macronutrients partially digested should be considered.

  17. Fuglestad MA, Thompson JS. Inflammatory bowel disease and short bowel syndrome. 2019 99:1209-1221

  18. Sulkowski JP, Minneci PC. Management of short bowel syndrome. 2014;21:111–8.

    Google Scholar 

  19. Rees PC. Nutritional considerations in the patient with gastroparesis. 2015;44:83–95.

    Google Scholar 

  20. Karamanolis G, Tack J. Nutrition and motility disorders. 2006;20:485–505.

    CAS  Google Scholar 

  21. Shah ND, Younkman J, Cornel L. Introduction to short bowel syndrome. Dietitians in medical nutrition therapy. 2020 1–6.

  22. Carteron L, Samain E, Winiszewski H, et al. Semi-elemental versus polymeric formula for enteral nutrition in brain-injured critically ill patients: a randomized trial. 2021;25:31.

    Google Scholar 

  23. Mayo Clinic. (2020). Inflammatory bowel disease (IBD). https://www.mayoclinic.org/diseases-conditions/inflammatory-bowel-disease/symptoms-causes/syc-20353315. Accessed February 2022

  24. Ghodeif AO, Azer SA. Pancreatic insufficiency. Treasure Island (FL): StatPearls Publishing; 2022.

    Google Scholar 

  25. Rees PC. Pancreatic exocrine insufficiency and enteral feeding: a practical guide with case studies. 2018;181(62):74.

    Google Scholar 

  26. Mayo Clinic. (2020). Gastroparesis. https://www.mayoclinic.org/diseases-conditions/gastroparesis/symptoms-causes/syc-20355787. Accessed February 2022

  27. Rangan V, Ukleja A. Gastroparesis in the hospital setting. 2020;36:50–66.

    Google Scholar 

  28. Bridges M. Dietary therapy for gastroparesis. 2021;23:311–21.

    Article  Google Scholar 

  29. Corrigan M, Bobo E, Rollins C, Mogensen K. Academy of nutrition and dietetics and American Society for parenteral and enteral nutrition: revised 2021 standards of practice and standards of professional performance for registered dietitian nutritionists (competent, proficient, and expert) in nutrition support. 2021 121:071–2086

  30. Sullivan J, Mascarenhas M. Nutrition: prevention and management of nutritional failure in cystic fibrosis. 2017 16:87–93

  31. Turck D, Braegger C, Colombo C, Wolfe S, Schneider S, Wilschanski M, et al. ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis. 2016 35:557–577

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology and Hepatology, University of Pennsylvania Health System, Philadelphia, USA

    Jessica Griffin MA R.D. LDN

Authors
  1. Jessica Griffin MA R.D. LDN
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jessica Griffin MA R.D. LDN.

Ethics declarations

Conflict of Interest

Jessica Griffin declares no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Nutrition and Obesity

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Griffin, J. Enteral Nutrition Therapy: Which Formula Do You Use?. Curr Treat Options Gastro 20, 392–405 (2022). https://doi.org/10.1007/s11938-022-00391-0

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11938-022-00391-0

Keywords

Search

Navigation